Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530512 · ClinicalTrials.gov registry record · NA
Acupuncture Therapy and Hypertension
A NA study of Mild to Moderate Hypertension, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 2
- Study locations
NCT05530512 is a NA study of Mild to Moderate Hypertension that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 72 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05530512, a NA study of Mild to Moderate Hypertension, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Conditions Studied
Interventions
- OTHER electroacupuncture
Study Locations (2)
California
- Susan Samueli Integrative Health Institute - Irvine
- University of California, Irvine, Health Sciences Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05530512
The ClinicalTrials.gov registry entry for NCT05530512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild to Moderate Hypertension appearing as the primary indexed condition, and to 1 intervention - of which electroacupuncture is the first listed.
NCT05530512 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05530512 about?
NCT05530512 is a clinical study titled "Acupuncture Therapy and Hypertension". Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
What is the current status of trial NCT05530512?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-01-01. Estimated completion is 2027-03-31.
What conditions does trial NCT05530512 study?
This clinical trial studies the following conditions: Mild to Moderate Hypertension.
What interventions are being tested in trial NCT05530512?
The interventions under investigation include: electroacupuncture (OTHER).
Who is sponsoring clinical trial NCT05530512?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05530512 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.